Clinical Trial Update: Therapeutic Resistance Prediction of Tyrosine Kinase Inhibitors

View source ↗

Summary

This clinical trial update discusses research on predicting resistance to tyrosine kinase inhibitors in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: Non-small Cell Lung Cancer | Status: UNKNOWN